{"bundle_type":"pith_open_graph_bundle","bundle_version":"1.0","pith_number":"pith:2013:QC7KJT26U77KOMQQ5SR445T6R5","short_pith_number":"pith:QC7KJT26","canonical_record":{"source":{"id":"1308.1087","kind":"arxiv","version":1},"metadata":{"license":"http://arxiv.org/licenses/nonexclusive-distrib/1.0/","primary_cat":"q-bio.OT","submitted_at":"2013-08-05T19:44:36Z","cross_cats_sorted":[],"title_canon_sha256":"c5de6f13a5872c92d7df1d2a4fbd17497e6b17f516e96a7096e2b44815a6cafe","abstract_canon_sha256":"022ec5747ab2e15a341a81fd941613f01a8edc2f8d6acd5f471b3d05bcb2157d"},"schema_version":"1.0"},"canonical_sha256":"80bea4cf5ea7fea73210eca3ce767e8f5f085a9e300f14f76830444f4bd83320","source":{"kind":"arxiv","id":"1308.1087","version":1},"source_aliases":[{"alias_kind":"arxiv","alias_value":"1308.1087","created_at":"2026-05-18T03:16:39Z"},{"alias_kind":"arxiv_version","alias_value":"1308.1087v1","created_at":"2026-05-18T03:16:39Z"},{"alias_kind":"doi","alias_value":"10.48550/arxiv.1308.1087","created_at":"2026-05-18T03:16:39Z"},{"alias_kind":"pith_short_12","alias_value":"QC7KJT26U77K","created_at":"2026-05-18T12:27:57Z"},{"alias_kind":"pith_short_16","alias_value":"QC7KJT26U77KOMQQ","created_at":"2026-05-18T12:27:57Z"},{"alias_kind":"pith_short_8","alias_value":"QC7KJT26","created_at":"2026-05-18T12:27:57Z"}],"events":[{"event_type":"record_created","subject_pith_number":"pith:2013:QC7KJT26U77KOMQQ5SR445T6R5","target":"record","payload":{"canonical_record":{"source":{"id":"1308.1087","kind":"arxiv","version":1},"metadata":{"license":"http://arxiv.org/licenses/nonexclusive-distrib/1.0/","primary_cat":"q-bio.OT","submitted_at":"2013-08-05T19:44:36Z","cross_cats_sorted":[],"title_canon_sha256":"c5de6f13a5872c92d7df1d2a4fbd17497e6b17f516e96a7096e2b44815a6cafe","abstract_canon_sha256":"022ec5747ab2e15a341a81fd941613f01a8edc2f8d6acd5f471b3d05bcb2157d"},"schema_version":"1.0"},"canonical_sha256":"80bea4cf5ea7fea73210eca3ce767e8f5f085a9e300f14f76830444f4bd83320","receipt":{"kind":"pith_receipt","key_id":"pith-v1-2026-05","algorithm":"ed25519","signed_at":"2026-05-18T03:16:39.817491Z","signature_b64":"+Gxdz4THjSP/pkv8amJNLMS7OwymF9eLfoEEHKMx6M8/f/2+7Vu8DH0i84thA9wAA5sjHaDdMnKuupdy1Ho6Aw==","signed_message":"canonical_sha256_bytes","builder_version":"pith-number-builder-2026-05-17-v1","receipt_version":"0.3","canonical_sha256":"80bea4cf5ea7fea73210eca3ce767e8f5f085a9e300f14f76830444f4bd83320","last_reissued_at":"2026-05-18T03:16:39.816756Z","signature_status":"signed_v1","first_computed_at":"2026-05-18T03:16:39.816756Z","public_key_fingerprint":"8d4b5ee74e4693bcd1df2446408b0d54"},"source_kind":"arxiv","source_id":"1308.1087","source_version":1,"attestation_state":"computed"},"signer":{"signer_id":"pith.science","signer_type":"pith_registry","key_id":"pith-v1-2026-05","public_key_fingerprint":"8d4b5ee74e4693bcd1df2446408b0d54"},"created_at":"2026-05-18T03:16:39Z","supersedes":[],"prev_event":null,"signature":{"signature_status":"signed_v1","algorithm":"ed25519","key_id":"pith-v1-2026-05","public_key_fingerprint":"8d4b5ee74e4693bcd1df2446408b0d54","signature_b64":"42ZyAkfh9ytbM/DRneygdxmNXCULuor0vJcabPXVC8PG6NGgrW7x446VLgfJ9VGwFlM1lpfjKGOFBshncQgGDA==","signed_message":"open_graph_event_sha256_bytes","signed_at":"2026-06-22T05:17:42.173715Z"},"content_sha256":"6dfdc7ddde752c83d1cc7033c9e5bd2eb5c9633fdd62cb355ac005dda187d936","schema_version":"1.0","event_id":"sha256:6dfdc7ddde752c83d1cc7033c9e5bd2eb5c9633fdd62cb355ac005dda187d936"},{"event_type":"graph_snapshot","subject_pith_number":"pith:2013:QC7KJT26U77KOMQQ5SR445T6R5","target":"graph","payload":{"graph_snapshot":{"paper":{"title":"Designing the statistically optimal drug for cancer therapy","license":"http://arxiv.org/licenses/nonexclusive-distrib/1.0/","headline":"","cross_cats":[],"primary_cat":"q-bio.OT","authors_text":"Konrad P. Kording, Marsha Rich Rosner, Patrick N. Lawlor, Robert Rosner, Stephen Quake, Tomer Kalisky","submitted_at":"2013-08-05T19:44:36Z","abstract_excerpt":"Cancer and healthy cells have distinct distributions of molecular properties and thus respond differently to drugs. Cancer drugs ideally kill cancer cells while limiting harm to healthy cells. However, the inherent variance among cells in both cancer and healthy cell populations increases the difficulty of selective drug action. Here we propose a classification framework based on the idea that an ideal cancer drug should maximally discriminate between cancer and healthy cells. We first explore how molecular markers can be used to discriminate cancer cells from healthy cells on a single cell ba"},"claims":{"count":0,"items":[],"snapshot_sha256":"258153158e38e3291e3d48162225fcdb2d5a3ed65a07baac614ab91432fd4f57"},"source":{"id":"1308.1087","kind":"arxiv","version":1},"verdict":{"id":null,"model_set":{},"created_at":null,"strongest_claim":"","one_line_summary":"","pipeline_version":null,"weakest_assumption":"","pith_extraction_headline":""},"references":{"count":0,"sample":[],"resolved_work":0,"snapshot_sha256":"258153158e38e3291e3d48162225fcdb2d5a3ed65a07baac614ab91432fd4f57","internal_anchors":0},"formal_canon":{"evidence_count":0,"snapshot_sha256":"258153158e38e3291e3d48162225fcdb2d5a3ed65a07baac614ab91432fd4f57"},"author_claims":{"count":0,"strong_count":0,"snapshot_sha256":"258153158e38e3291e3d48162225fcdb2d5a3ed65a07baac614ab91432fd4f57"},"builder_version":"pith-number-builder-2026-05-17-v1"},"verdict_id":null},"signer":{"signer_id":"pith.science","signer_type":"pith_registry","key_id":"pith-v1-2026-05","public_key_fingerprint":"8d4b5ee74e4693bcd1df2446408b0d54"},"created_at":"2026-05-18T03:16:39Z","supersedes":[],"prev_event":null,"signature":{"signature_status":"signed_v1","algorithm":"ed25519","key_id":"pith-v1-2026-05","public_key_fingerprint":"8d4b5ee74e4693bcd1df2446408b0d54","signature_b64":"YRsGGLok66VvJLhTH+59TeoUlOlkW/QodQBkrPTe7hpIX18rOVlfJKNw+vWSLEGcKdW4R+VI/D+5X2cVy+2vCg==","signed_message":"open_graph_event_sha256_bytes","signed_at":"2026-06-22T05:17:42.174054Z"},"content_sha256":"57aa4d6a9c741a10d0e634054bed209813ba561fbfe689361c833e1e44ee74d3","schema_version":"1.0","event_id":"sha256:57aa4d6a9c741a10d0e634054bed209813ba561fbfe689361c833e1e44ee74d3"}],"timestamp_proofs":[],"mirror_hints":[{"mirror_type":"https","name":"Pith Resolver","base_url":"https://pith.science","bundle_url":"https://pith.science/pith/QC7KJT26U77KOMQQ5SR445T6R5/bundle.json","state_url":"https://pith.science/pith/QC7KJT26U77KOMQQ5SR445T6R5/state.json","well_known_bundle_url":"https://pith.science/.well-known/pith/QC7KJT26U77KOMQQ5SR445T6R5/bundle.json","status":"primary"}],"public_keys":[{"key_id":"pith-v1-2026-05","algorithm":"ed25519","format":"raw","public_key_b64":"stVStoiQhXFxp4s2pdzPNoqVNBMojDU/fJ2db5S3CbM=","public_key_hex":"b2d552b68890857171a78b36a5dccf368a953413288c353f7c9d9d6f94b709b3","fingerprint_sha256_b32_first128bits":"RVFV5Z2OI2J3ZUO7ERDEBCYNKS","fingerprint_sha256_hex":"8d4b5ee74e4693bcd1df2446408b0d54","rotates_at":null,"url":"https://pith.science/pith-signing-key.json","notes":"Pith uses this Ed25519 key to sign canonical record SHA-256 digests. Verify with: ed25519_verify(public_key, message=canonical_sha256_bytes, signature=base64decode(signature_b64))."}],"merge_version":"pith-open-graph-merge-v1","built_at":"2026-06-22T05:17:42Z","links":{"resolver":"https://pith.science/pith/QC7KJT26U77KOMQQ5SR445T6R5","bundle":"https://pith.science/pith/QC7KJT26U77KOMQQ5SR445T6R5/bundle.json","state":"https://pith.science/pith/QC7KJT26U77KOMQQ5SR445T6R5/state.json","well_known_bundle":"https://pith.science/.well-known/pith/QC7KJT26U77KOMQQ5SR445T6R5/bundle.json"},"state":{"state_type":"pith_open_graph_state","state_version":"1.0","pith_number":"pith:2013:QC7KJT26U77KOMQQ5SR445T6R5","merge_version":"pith-open-graph-merge-v1","event_count":2,"valid_event_count":2,"invalid_event_count":0,"equivocation_count":0,"current":{"canonical_record":{"metadata":{"abstract_canon_sha256":"022ec5747ab2e15a341a81fd941613f01a8edc2f8d6acd5f471b3d05bcb2157d","cross_cats_sorted":[],"license":"http://arxiv.org/licenses/nonexclusive-distrib/1.0/","primary_cat":"q-bio.OT","submitted_at":"2013-08-05T19:44:36Z","title_canon_sha256":"c5de6f13a5872c92d7df1d2a4fbd17497e6b17f516e96a7096e2b44815a6cafe"},"schema_version":"1.0","source":{"id":"1308.1087","kind":"arxiv","version":1}},"source_aliases":[{"alias_kind":"arxiv","alias_value":"1308.1087","created_at":"2026-05-18T03:16:39Z"},{"alias_kind":"arxiv_version","alias_value":"1308.1087v1","created_at":"2026-05-18T03:16:39Z"},{"alias_kind":"doi","alias_value":"10.48550/arxiv.1308.1087","created_at":"2026-05-18T03:16:39Z"},{"alias_kind":"pith_short_12","alias_value":"QC7KJT26U77K","created_at":"2026-05-18T12:27:57Z"},{"alias_kind":"pith_short_16","alias_value":"QC7KJT26U77KOMQQ","created_at":"2026-05-18T12:27:57Z"},{"alias_kind":"pith_short_8","alias_value":"QC7KJT26","created_at":"2026-05-18T12:27:57Z"}],"graph_snapshots":[{"event_id":"sha256:57aa4d6a9c741a10d0e634054bed209813ba561fbfe689361c833e1e44ee74d3","target":"graph","created_at":"2026-05-18T03:16:39Z","signer":{"key_id":"pith-v1-2026-05","public_key_fingerprint":"8d4b5ee74e4693bcd1df2446408b0d54","signer_id":"pith.science","signer_type":"pith_registry"},"payload":{"graph_snapshot":{"author_claims":{"count":0,"snapshot_sha256":"258153158e38e3291e3d48162225fcdb2d5a3ed65a07baac614ab91432fd4f57","strong_count":0},"builder_version":"pith-number-builder-2026-05-17-v1","claims":{"count":0,"items":[],"snapshot_sha256":"258153158e38e3291e3d48162225fcdb2d5a3ed65a07baac614ab91432fd4f57"},"formal_canon":{"evidence_count":0,"snapshot_sha256":"258153158e38e3291e3d48162225fcdb2d5a3ed65a07baac614ab91432fd4f57"},"paper":{"abstract_excerpt":"Cancer and healthy cells have distinct distributions of molecular properties and thus respond differently to drugs. Cancer drugs ideally kill cancer cells while limiting harm to healthy cells. However, the inherent variance among cells in both cancer and healthy cell populations increases the difficulty of selective drug action. Here we propose a classification framework based on the idea that an ideal cancer drug should maximally discriminate between cancer and healthy cells. We first explore how molecular markers can be used to discriminate cancer cells from healthy cells on a single cell ba","authors_text":"Konrad P. Kording, Marsha Rich Rosner, Patrick N. Lawlor, Robert Rosner, Stephen Quake, Tomer Kalisky","cross_cats":[],"headline":"","license":"http://arxiv.org/licenses/nonexclusive-distrib/1.0/","primary_cat":"q-bio.OT","submitted_at":"2013-08-05T19:44:36Z","title":"Designing the statistically optimal drug for cancer therapy"},"references":{"count":0,"internal_anchors":0,"resolved_work":0,"sample":[],"snapshot_sha256":"258153158e38e3291e3d48162225fcdb2d5a3ed65a07baac614ab91432fd4f57"},"source":{"id":"1308.1087","kind":"arxiv","version":1},"verdict":{"created_at":null,"id":null,"model_set":{},"one_line_summary":"","pipeline_version":null,"pith_extraction_headline":"","strongest_claim":"","weakest_assumption":""}},"verdict_id":null}}],"author_attestations":[],"timestamp_anchors":[],"storage_attestations":[],"citation_signatures":[],"replication_records":[],"corrections":[],"mirror_hints":[],"record_created":{"event_id":"sha256:6dfdc7ddde752c83d1cc7033c9e5bd2eb5c9633fdd62cb355ac005dda187d936","target":"record","created_at":"2026-05-18T03:16:39Z","signer":{"key_id":"pith-v1-2026-05","public_key_fingerprint":"8d4b5ee74e4693bcd1df2446408b0d54","signer_id":"pith.science","signer_type":"pith_registry"},"payload":{"attestation_state":"computed","canonical_record":{"metadata":{"abstract_canon_sha256":"022ec5747ab2e15a341a81fd941613f01a8edc2f8d6acd5f471b3d05bcb2157d","cross_cats_sorted":[],"license":"http://arxiv.org/licenses/nonexclusive-distrib/1.0/","primary_cat":"q-bio.OT","submitted_at":"2013-08-05T19:44:36Z","title_canon_sha256":"c5de6f13a5872c92d7df1d2a4fbd17497e6b17f516e96a7096e2b44815a6cafe"},"schema_version":"1.0","source":{"id":"1308.1087","kind":"arxiv","version":1}},"canonical_sha256":"80bea4cf5ea7fea73210eca3ce767e8f5f085a9e300f14f76830444f4bd83320","receipt":{"algorithm":"ed25519","builder_version":"pith-number-builder-2026-05-17-v1","canonical_sha256":"80bea4cf5ea7fea73210eca3ce767e8f5f085a9e300f14f76830444f4bd83320","first_computed_at":"2026-05-18T03:16:39.816756Z","key_id":"pith-v1-2026-05","kind":"pith_receipt","last_reissued_at":"2026-05-18T03:16:39.816756Z","public_key_fingerprint":"8d4b5ee74e4693bcd1df2446408b0d54","receipt_version":"0.3","signature_b64":"+Gxdz4THjSP/pkv8amJNLMS7OwymF9eLfoEEHKMx6M8/f/2+7Vu8DH0i84thA9wAA5sjHaDdMnKuupdy1Ho6Aw==","signature_status":"signed_v1","signed_at":"2026-05-18T03:16:39.817491Z","signed_message":"canonical_sha256_bytes"},"source_id":"1308.1087","source_kind":"arxiv","source_version":1}}},"equivocations":[],"invalid_events":[],"applied_event_ids":["sha256:6dfdc7ddde752c83d1cc7033c9e5bd2eb5c9633fdd62cb355ac005dda187d936","sha256:57aa4d6a9c741a10d0e634054bed209813ba561fbfe689361c833e1e44ee74d3"],"state_sha256":"209f1280111049f6131ac4b8b9e42a2a17dc47cf20410b7c37d2a80cbd2a71b9"},"bundle_signature":{"signature_status":"signed_v1","algorithm":"ed25519","key_id":"pith-v1-2026-05","public_key_fingerprint":"8d4b5ee74e4693bcd1df2446408b0d54","signature_b64":"EycpfUVEmhhkHzkezyvGBN/eaPRzY5JwHQ2lQV1vXCFmRgMMJ0jU2jVzO20+PziV9L6JDZ6BlMhnoL5S0V1uCQ==","signed_message":"bundle_sha256_bytes","signed_at":"2026-06-22T05:17:42.175976Z","bundle_sha256":"9419ad04f90e832339a3408e5bdcb4c3b8f744d5f6b0b04486285bd37a9a6d06"}}